Early Access

10-QPeriod: Q3 FY2016

UNITEDHEALTH GROUP INC Quarterly Report for Q3 Ended Sep 30, 2016

Filed November 8, 2016For Securities:UNH

Summary

UnitedHealth Group Inc. (UNH) reported strong financial performance for the nine months ended September 30, 2016, with total revenues increasing by 21% to $137.3 billion, driven by significant growth in both its UnitedHealthcare and Optum segments. Net earnings attributable to common shareholders rose by 16% to $5.33 billion, reflecting a diluted EPS of $5.51. The company also demonstrated robust cash flow generation, with operating activities providing $11.2 billion. This period saw strategic execution, including the successful integration of the Catamaran acquisition, which bolstered the OptumRx segment. Despite ongoing regulatory pressures and competitive market dynamics, UNH maintained a healthy financial position and demonstrated its commitment to shareholder returns through increased dividend payouts and share repurchases. The company's diversified business model, spanning health benefits and technology-enabled health services, continues to prove resilient. UnitedHealthcare experienced growth across its Employer & Individual, Medicare & Retirement, and Community & State businesses, serving an additional 2.1 million domestic individuals. The Optum segment showed particularly strong performance, with OptumRx benefiting from the Catamaran acquisition and OptumInsight and OptumHealth delivering solid revenue and earnings growth. UNH's proactive management of medical costs and operating expenses contributed to improved earnings from operations, up 14% year-over-year, showcasing effective operational execution.

Financial Statements
Beta
Revenue$46.29B
Cost of Revenue$6.13B
Gross Profit$40.17B
SG&A Expenses$7.03B
Operating Expenses$42.71B
Operating Income$3.58B
Interest Expense$269.00M
Net Income$1.97B
EPS (Basic)$2.07
EPS (Diluted)$2.03
Shares Outstanding (Basic)952.00M
Shares Outstanding (Diluted)969.00M

Key Highlights

  • 1Total revenues increased 21% year-over-year to $137.3 billion for the nine months ended September 30, 2016.
  • 2Net earnings attributable to common shareholders grew 16% to $5.33 billion, with diluted EPS reaching $5.51.
  • 3Cash flows from operating activities were strong, totaling $11.2 billion for the nine months ended September 30, 2016.
  • 4UnitedHealthcare served an additional 2.1 million domestic individuals, demonstrating broad-based growth across its business lines.
  • 5The Optum segment experienced a 34% revenue increase, driven significantly by the integration of Catamaran and growth in OptumRx.
  • 6Earnings from operations increased by 14% to $9.74 billion, reflecting operational efficiencies and segment strength.
  • 7The company increased its quarterly cash dividend to an annual rate of $2.50 per share, signaling confidence in future performance and commitment to shareholder returns.

Frequently Asked Questions